These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Adjunctive treatment of sepsis]. Max M Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Jan; 41(1):41-2. PubMed ID: 16440261 [No Abstract] [Full Text] [Related]
5. Management of sepsis in the ICU. Trejnowska E; Popovich MJ Int Anesthesiol Clin; 2009; 47(1):55-66. PubMed ID: 19131752 [No Abstract] [Full Text] [Related]
6. Inflammation and coagulation: implications for the septic patient. Dellinger RP Clin Infect Dis; 2003 May; 36(10):1259-65. PubMed ID: 12746771 [TBL] [Abstract][Full Text] [Related]
7. [Supportive treatment measures in severe sepsis]. Sablotzki A; Dehne MG; Czeslick E Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Jan; 41(1):37-41. PubMed ID: 16440260 [No Abstract] [Full Text] [Related]
8. Development and implementation of a multidisciplinary sepsis protocol. Picard KM; O'Donoghue SC; Young-Kershaw DA; Russell KJ Crit Care Nurse; 2006 Jun; 26(3):43-54. PubMed ID: 16717386 [No Abstract] [Full Text] [Related]
9. Treatment options for severe sepsis and septic shock. Sharma VK; Dellinger RP Expert Rev Anti Infect Ther; 2006 Jun; 4(3):395-403. PubMed ID: 16771617 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive corticosteroid therapy in pediatric severe sepsis: many unsolved questions. Leclerc F; Botte A; ChĂȘne G; Leteurtre S Pediatr Crit Care Med; 2011 Jan; 12(1):101-2. PubMed ID: 21209569 [No Abstract] [Full Text] [Related]
11. Immunomodulation in sepsis: state of the art and future perspective. Antonopoulou A; Giamarellos-Bourboulis EJ Immunotherapy; 2011 Jan; 3(1):117-28. PubMed ID: 21174562 [TBL] [Abstract][Full Text] [Related]
12. Sepsis: state of the art. Marik PE; Varon J Dis Mon; 2001 Oct; 47(10):465-532. PubMed ID: 11641650 [No Abstract] [Full Text] [Related]
13. The implementation of new therapies for severe sepsis: some questions raised by "early goal-directed therapy, corticosteroid, and recombinant human activated protein c for the treatment of severe sepsis and septic shock in the emergency department". Gaieski D; Goyal M Acad Emerg Med; 2006 Sep; 13(9):997-9; author reply 999-1000. PubMed ID: 16825672 [No Abstract] [Full Text] [Related]
14. Adjunctive corticosteroid therapy in pediatric severe sepsis: observations from the RESOLVE study. Zimmerman JJ; Williams MD Pediatr Crit Care Med; 2011 Jan; 12(1):2-8. PubMed ID: 20228689 [TBL] [Abstract][Full Text] [Related]
15. An update on the pathophysiology of sepsis. le Roux P SADJ; 2004 May; 59(4):163, 165. PubMed ID: 15279093 [TBL] [Abstract][Full Text] [Related]
16. Sepsis in the 21st century: recent definitions and therapeutic advances. Nguyen HB; Smith D Am J Emerg Med; 2007 Jun; 25(5):564-71. PubMed ID: 17543662 [TBL] [Abstract][Full Text] [Related]
17. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department. Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336 [TBL] [Abstract][Full Text] [Related]
18. Evidence-based therapies for sepsis care in the emergency department: striking a balance between feasibility and necessity. Jones AE Acad Emerg Med; 2006 Jan; 13(1):82-3. PubMed ID: 16365339 [No Abstract] [Full Text] [Related]